Trial Details
COMPLETEDBasic Information
| Clinical ID | c944 |
|---|---|
| Identifier | NCT04112212 |
| Trial Title | Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Colitis, Ulcerative |
| Interventions | DRUG: Fluorescence molecular imaging procedure using vedolizumab-800CW|OTHER: Fluorescence molecular imaging procedure without prior administration of vedolizumab-800CW|COMBINATION_PRODUCT: Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration of unlabeled vedolizumab |
Participant Information
| Sponsor | University Medical Center Groningen |
|---|---|
| City | Groningen |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2020-11-04 |
|---|---|
| Primary Completion Date | 2022-10-01 |
| Completion Date | 2023-01-01 |